Navigation Links
New 'armor' developed to avoid infection from AIDS virus
Date:7/30/2010

The doors are closing on the AIDS virus. The scientific community continues to strive to find the formula that will halt the advance of one of the viruses that has sparked most scientific interest over recent years. A study by the Consejo Superior de Investigaciones Cientficas (CSIC) and led by Mr Flix Goi, director of the Biophysics Unit at the CSIC-University of the Basque Country Mixed Centre, has developed a method of attack against the AIDS virus The method involves creating a prevention system, i.e. an 'armour' in the cells that are likely to be infected and thus impede, de facto, the virus from accessing them and starting to act on their immunological system.

The research study lays down the bases of possible future pharmaceutical drugs that will enable combating the AIDS virus at its initial phase and has been published in the prestigious journal Chemistry & Biology of the Cell Group. Participating in the research, apart from Mr Goi, was a team from the National Biotechnology Centre (CSIC-Universidad Autnoma de Madrid) and another from the Institute of Applied Chemistry of Cataloniaa (CSIC, Barcelona). The article is entitled "Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains".

The study provides a new, hitherto unexplored focus on scientific research. This pioneering contribution on the AIDS virus is based on the regulation of the fluidity of the cell membranes and seeks to avoid the phenomenon known as the fusion of membranes, a consequence of contact between the cell membranes and the membrane of the virus itself.

The membrane is the "coating" of the cell cytoplasm and which protects it from the outside, and which has a structure similar to that of the membranes of the AIDS virus. When both membranes come into contact, and due to the fact that the cell membrane is very "fragile", an orifice is created and fusion occurs and a route is opened for the AIDS virus to enter,
'/>"/>

Contact: Oihane Lakar
o.lakar@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. In the war against diseases, nerve cells need their armor
2. Researchers find chink in the armor of viral tummy bug
3. The fantastic armor of a wonder snail
4. National Institutes of Health Secures Armory with Patent-Pending Technology
5. Rare armor-plated creature discovered in Canadas capital
6. Real-time gene monitoring developed
7. New vaccine developed for preventing uncommon cold virus
8. New pollution radar developed to provide unprecedented picture of urban smog
9. First tri-continuous mesoporous Silica complex structure developed in Singapore
10. New method developed by UC San Diego bioengineers gives regenerative medicine a boost
11. Rapid approach to identify influenza A virus mutations and drug resistance developed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New 'armor' developed to avoid infection from AIDS virus
(Date:1/22/2015)... Jan. 16, 2015  A man-made form of insulin delivered ... mental capabilities in adults with mild cognitive impairment and ... by researchers at Wake Forest Baptist Medical Center. ... amnesic mild cognitive impairment (MCI) or mild to moderate ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) ... Wearable Technologies Market and Applications, Opportunities, Industry Analysis, ... 2014-2020" report to their offering. , ... can be worn on the user,s body and ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... addition of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... digital media watermarking and fingerprinting markets. Watermarking aims ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2The Global Watermarking and Fingerprinting Markets 2
... first time, researchers have developed a way to synthesize a ... it works. , Derived from a fungus discovered clinging to ... certain cancer cells into suicide while leaving healthy cells untouched. ... might have some tremendous potential as a prototype anticancer agent, ...
... cell count" burst into the world's medical vocabulary as ... The public began to understand the crucial importance of ... infection and guarding against future attacks. , While scientists ... diseases, one area has remained murky: disorders caused by ...
... together, and most people find it impossible to tell ... just about everything, including their genes. But sometimes only ... both of them should. , Scientists at the University ... how two people who are so similar biologically can ...
Cached Biology News:New lab technique churns out fungus' potential cancer fighter 2Researchers add crucial information on how the body's T cells react to parasitic diseases 2Researchers add crucial information on how the body's T cells react to parasitic diseases 3How can identical twins be genetically different? 2How can identical twins be genetically different? 3
(Date:1/22/2015)... 22, 2015 Protocol Networks brings independent ... team of brand-neutral, independent consultants, Protocol Networks has recently ... that over the years, his company has attracted several ... of Plainfield, as well as others. With the success ...
(Date:1/22/2015)... zFlo Motion , a US leader in ... product from a new partner. STT-Systems has developed ... 15 years, with offerings in the optical-motion capture, 3D scanning, ... (inertial measurement unit), iSen, is opening eyes around the world. ...
(Date:1/22/2015)... Selexis SA, a serial innovation company with proven ... for drug discovery to commercial manufacturing, announced today all ... Sequencing (NGS) data packages. The NGS analysis of ... the integrity of the gene, validation of the left ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 23D Motion Capture Just Got Easy 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... Non-GAAP EPS Increased 22 Percent, CAMBRIDGE, Mass., April 23 ... the first quarter of,2008, which featured excellent revenue growth, continued ... the company., First-Quarter Highlights -- Total revenue ... $883.2 million in same period a ...
... Cardiac Science,Corporation (Nasdaq: CSCX ), a ... informatics products, announced today,that it will release its ... 2008 after the market close. The Company has ... 4:30 p.m. Eastern Time to,discuss the financial results ...
... image are better than one for analyzing tumors , ... determine the amount of oxygen in a tumor very useful, because ... a poor outcome. A new method to do this and to ... been developed and used to image tumors in mice by Murali ...
Cached Biology Technology:Genzyme Reports Strong First-Quarter Growth 2Genzyme Reports Strong First-Quarter Growth 3Genzyme Reports Strong First-Quarter Growth 4Genzyme Reports Strong First-Quarter Growth 5Genzyme Reports Strong First-Quarter Growth 6Genzyme Reports Strong First-Quarter Growth 7Genzyme Reports Strong First-Quarter Growth 8Genzyme Reports Strong First-Quarter Growth 9Genzyme Reports Strong First-Quarter Growth 10Genzyme Reports Strong First-Quarter Growth 11Genzyme Reports Strong First-Quarter Growth 12Genzyme Reports Strong First-Quarter Growth 13Genzyme Reports Strong First-Quarter Growth 14Genzyme Reports Strong First-Quarter Growth 15Genzyme Reports Strong First-Quarter Growth 16Genzyme Reports Strong First-Quarter Growth 17Genzyme Reports Strong First-Quarter Growth 18Genzyme Reports Strong First-Quarter Growth 19Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 2JCI table of contents: April 22, 2008 2JCI table of contents: April 22, 2008 3JCI table of contents: April 22, 2008 4JCI table of contents: April 22, 2008 5JCI table of contents: April 22, 2008 6JCI table of contents: April 22, 2008 7JCI table of contents: April 22, 2008 8JCI table of contents: April 22, 2008 9JCI table of contents: April 22, 2008 10JCI table of contents: April 22, 2008 11JCI table of contents: April 22, 2008 12
... can be used for efficient, mild and ... for ELISA or other assays for protein ... are bound with high efficiency to the ... will not elute during the assay due ...
... label printer is portable, easy-to-use and makes identifying ... Easy to use Labels ... and slide sizes Time/Date stamp ... one Serialization feature makes you more ...
Activating Agents, 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate...
Each 72-well MiniTray is low profile, with lid. Conical well shape, 10 l....
Biology Products: